JP Morgan Chase
DARE icon

JP Morgan Chase’s Dare Bioscience DARE Stock Holding History

JP Morgan Chase’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-19
Closed -$55 – 7186
2025
Q1 		$55 Sell
19
-2
-10% -$6 ﹤0.01% 6970
2024
Q4 		$66 Hold
21
– – ﹤0.01% 7072
2024
Q3 		$68 Hold
21
– – ﹤0.01% 7063
2024
Q2 		$84 Buy
21
+1
+5% +$5 ﹤0.01% 6918
2024
Q1 		$117 Sell
20
-1,005
-98% -$4.92K ﹤0.01% 6879
2023
Q4 		$3.8K Buy
1,025
+1,016
+11,289% +$4.64K ﹤0.01% 6606
2023
Q3 		$48 Buy
+9
New +$74 ﹤0.01% 7003
2023
Q2 		– Sell
-780
Closed -$10K – 6980
2023
Q1 		$10K Buy
+780
New +$10.4K ﹤0.01% 6114
2019
Q1 		– Sell
-20
Closed – – 5803
2018
Q4 		$0 Buy
+20
New +$211 ﹤0.01% 5725
2014
Q3 		– Sell
-1,304
Closed -$908K – 4193
2014
Q2 		$908K Buy
+1,304
New +$1.01M ﹤0.01% 2885

Other funds holding DARE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AE
AMH Equity Great Neck, New York $80.3M AUM 78.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase's DARE Position: Q2 2025 in Review

JP Morgan Chase sold out of Dare Bioscience (DARE) in Q2 2025, closing a stake of 19 shares — an estimated $55 sold.

JP Morgan Chase first reported a position in DARE in Q2 2014 and held it in 10 quarters. The position peaked at $908K in Q2 2014. 23 funds tracked by Wall St. Rank hold DARE as of Q2 2025.

  • JP Morgan Chase reported no remaining Dare Bioscience position as of Q2 2025 after selling out during the quarter.
  • JP Morgan Chase sold 19 Dare Bioscience shares in Q2 2025, an estimated $55.
  • JP Morgan Chase first reported a position in Dare Bioscience in Q2 2014 and held it in 10 quarters.
  • JP Morgan Chase's Dare Bioscience position peaked at $908K in Q2 2014.
  • 23 funds tracked by Wall St. Rank held Dare Bioscience as of Q2 2025.

Based on JP Morgan Chase's 13F filing for Q2 2025, filed 12 Aug 2025.